Literature DB >> 20416074

Burkitt's lymphoma mimicking EBV disease as first sign of vertical HIV infection in an adolescent.

Veronica Santilli1, Nadia Mora, Angela Aquilani, Hyppolite K Tchidjou, Giuseppe Pontrelli, Rita De Vito, Alessandra Lombardi, Stefania Bernardi, Paolo Palma.   

Abstract

Burkitt's Lymphoma (BL) rarely represents the first clinical manifestation of vertical HIV infection in adolescent in Western Europe. We report the case of a 17 year-old boy with two week history of fever and enlarged cervical lymph nodes firstly misdiagnosed as EBV infection, subsequently diagnosed as Burkitt's Lymphoma and vertical HIV infection.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20416074      PMCID： PMC2873400          DOI： 10.1186/1824-7288-36-34

Source DB:  PubMed          Journal:  Ital J Pediatr        ISSN： 1720-8424            Impact factor:   2.638


  24 in total

Review 1.  Modern management of non-Hodgkin lymphoma in HIV-infected patients.

Authors:  Nicolas Mounier; Michele Spina; Christian Gisselbrecht
Journal:  Br J Haematol       Date:  2006-12-01       Impact factor: 6.998

2.  Prospective study of human immunodeficiency virus 1-related disease among 512 infants born to infected women in New York City. The New York City Perinatal HIV Transmission Collaborative Study Group.

Authors:  M Bamji; D M Thea; J Weedon; K Krasinski; P B Matheson; P Thomas; G Lambert; E J Abrams; R Steketee; M Heagarty
Journal:  Pediatr Infect Dis J       Date:  1996-10       Impact factor: 2.129

Review 3.  Cancers in children with HIV infection.

Authors:  K L McClain; V V Joshi; S B Murphy
Journal:  Hematol Oncol Clin North Am       Date:  1996-10       Impact factor: 3.722

4.  HIV-associated malignancies in children.

Authors:  B U Mueller
Journal:  AIDS Patient Care STDS       Date:  1999-09       Impact factor: 5.078

5.  Human immunodeficiency virus-related cancer in children: incidence and treatment outcome--report of the Italian Register.

Authors:  D Caselli; C Klersy; M de Martino; C Gabiano; L Galli; P A Tovo; M Aricò
Journal:  J Clin Oncol       Date:  2000-11-15       Impact factor: 44.544

6.  Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.

Authors: 
Journal:  J Natl Cancer Inst       Date:  2000-11-15       Impact factor: 13.506

7.  Natural history of vertically acquired human immunodeficiency virus-1 infection. The European Collaborative Study.

Authors: 
Journal:  Pediatrics       Date:  1994-12       Impact factor: 7.124

8.  Epstein Barr virus-associated lymphoma in HIV-infected children.

Authors:  María Victoria Preciado; Aurelia Fallo; Paola Chabay; Laura Calcagno; Elena De Matteo
Journal:  Pathol Res Pract       Date:  2002       Impact factor: 3.250

9.  Cancer incidence in people with AIDS in Italy.

Authors:  Jerry Polesel; Silvia Franceschi; Barbara Suligoi; Emanuele Crocetti; Fabio Falcini; Stefano Guzzinati; Marina Vercelli; Roberto Zanetti; Giovanna Tagliabue; Antonio Russo; Stefano Luminari; Fabrizio Stracci; Vincenzo De Lisi; Stefano Ferretti; Lucia Mangone; Mario Budroni; Rosa Maria Limina; Silvano Piffer; Diego Serraino; Francesco Bellù; Adriano Giacomin; Andrea Donato; Anselmo Madeddu; Susanna Vitarelli; Mario Fusco; Roberto Tessandori; Rosario Tumino; Pierluca Piselli; Luigino Dal Maso; Mauro Lise; Antonella Zucchetto; Angela De Paoli; Teresa Intrieri; Rosa Vattiato; Paola Zambon; Antonella Puppo; Silvia Patriarca; Andrea Tittarelli; Mariangela Autelitano; Claudia Cirilli; Francesco La Rosa; Paolo Sgargi; Enza Di Felice; Rosaria Cesaraccio; Francesco Donato; Silva Franchini; Loris Zanier; Fabio Vittadello; Pier Carlo Vercellino; Gennaro Senatore; Maria Lia Contrino; Silvia Antonini; Raffaele Palombino; Sergio Maspero; Maria Guglielmina La Rosa; Laura Camoni; Vincenza Regine
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

Review 10.  HIV infection and lymphoma.

Authors:  K L Grogg; R F Miller; A Dogan
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.